Loading…
Lifecore Biomedical, Inc. is projected to rise to $6.31 by 2027, a +43% move from its current price of $4.42. LFCR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $4.32 | $4.42 | $4.53 | +0.10% |
| Aug 5 | $4.28 | $4.43 | $4.58 | +0.20% |
| Aug 6 | $4.25 | $4.43 | $4.62 | +0.30% |
| Aug 7 | $4.23 | $4.44 | $4.66 | +0.40% |
| Aug 8 | $4.21 | $4.44 | $4.69 | +0.50% |
| Aug 9 | $4.19 | $4.45 | $4.72 | +0.60% |
| Aug 10 | $4.17 | $4.45 | $4.75 | +0.70% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.17 | $4.45 | $4.75 | +0.70% |
| Week 2 | $4.09 | $4.48 | $4.91 | +1.41% |
| Week 3 | $4.04 | $4.51 | $5.05 | +2.12% |
| Week 4 | $3.99 | $4.55 | $5.17 | +2.83% |
| Week 5 | $3.96 | $4.58 | $5.29 | +3.55% |
| Week 6 | $3.93 | $4.61 | $5.40 | +4.28% |
| Week 7 | $3.91 | $4.64 | $5.51 | +5.01% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Lifecore Biomedical, Inc., and its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities.
The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc.
in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Lifecore Biomedical, Inc. (LFCR) is a healthcare company operating in the contract development and manufacturing space, including aseptic fill and finish for injectable products and related hyaluronic acid materials. The asset is currently priced at $4.58 and trades with a market cap of $171.79M, ranking 3754.
The latest price action sits in a range shaped by nearby technical levels and a mid-cap footprint within its sector. The forecasted path shows meaningful upside over the coming years, with multi-year targets extending well beyond the current price.
A major floor 23.8% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.3% away) — a key level to hold.
The nearest ceiling, 31.2% above — a clean break opens room to run.
A major ceiling 43.1% above — clearing it would confirm fresh momentum.
Key LFCR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LFCR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.37 | Buy | $4.39 | Buy |
| MA 10 | $4.45 | Sell | $4.46 | Sell |
| MA 20 | $4.61 | Sell | $4.62 | Sell |
| MA 50 | $5.04 | Sell | $4.89 | Sell |
| MA 100 | $4.90 | Sell | $5.26 | Sell |
| MA 200 | $6.24 | Sell | $5.82 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 39.08 | Neutral |
| Stoch RSI (14) | 38.76 | Neutral |
| CCI (20) | -72.36 | Neutral |
| Williams %R (14) | -84.13 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -9.05 | Sell |
| Bollinger %B (20,2) | 0.28 | Neutral |
| Stochastic %K (14) | 15.87 | Buy |
| TRIX (15) | -0.58 | Sell |
| Awesome (5,34) | -0.57 | Sell |
| Ultimate (7,14,28) | 35.86 | Neutral |
| Momentum (10) | -0.26 | Sell |
| Aroon Osc (25) | -92.00 | Sell |
| Hull MA (9) | 4.34 | Buy |
| ADX (14) | 21.75 | Sell |
| ATR (14) | 0.10 | Info |
The 30-day technical picture shows a neutral posture with key levels nearby. The RSI(14) is 40, indicating modest momentum. The nearby moving averages sit at $5.05 for the SMA50 and $6.32 for the SMA200, outlining resistance above the current price. Support is identified at $4.57, with a resistance at $5.80.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.66 | $4.42 | $6.26 | 0% | Neutral | |
| $5.08 | $6.31 | $8.26 | +43% | Bullish | |
| $5.68 | $7.24 | $9.79 | +64% | Bullish | |
| $6.30 | $8.19 | $11.38 | +85% | Bullish | |
| $6.71 | $8.87 | $12.61 | +101% | Bullish | |
| $7.14 | $9.61 | $13.92 | +117% | Bullish | |
| $7.46 | $10.19 | $15.03 | +131% | Bullish | |
| $8.73 | $12.10 | $18.13 | +174% | Bullish | |
| $10.66 | $14.97 | $22.77 | +239% | Bullish | |
| $11.24 | $15.99 | $24.65 | +262% | Bullish | |
| $15.48 | $23.33 | $38.08 | +428% | Bullish | |
| $29.15 | $48.48 | $86.02 | +997% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $3.66 | $4.42 | $5.33 | +0.00% |
| September 2026 | $3.98 | $4.69 | $5.67 | +6.09% |
| October 2026 | $4.08 | $4.84 | $5.91 | +3.23% |
| November 2026 | $4.08 | $4.86 | $5.99 | +0.49% |
| December 2026 | $4.21 | $5.05 | $6.26 | +3.73% |
Click any year to see its month-by-month LFCR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, LFCR could reach as high as $6.26, with a base case around $4.42 and support toward $3.66 — roughly 0% from $4.42. Price action looks broadly range-bound.
Expect LFCR to range from $5.08 to $8.26 through 2027. The $6.31 average target implies a +43% move from current prices. That is up +43% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The LFCR price prediction for 2028 points to an average of $7.24 (low $5.68, high $9.79) — a potential gain of +64% on today's $4.42. Momentum favours further upside here.
In 2029, LFCR is projected to trade between $6.30 and $11.38, averaging $8.19 — a potential gain of +85% from today's $4.42. That is up +13% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Lifecore Biomedical, Inc.'s 2030 outlook centres on $8.87, within a $6.71 to $12.61 range. That is up +8% on the projected 2029 average. That marks a +101% change versus current levels. Momentum favours further upside here.
By 2031, LFCR could reach as high as $13.92, with a base case around $9.61 and support toward $7.14 — roughly +117% from $4.42. Buyers look set to stay in control over this stretch.
Expect LFCR to range from $7.46 to $15.03 through 2032. The $10.19 average target implies a +131% move from current prices. That is up +6% on the projected 2031 average. Momentum favours further upside here.
The LFCR price prediction for 2033 points to an average of $12.10 (low $8.73, high $18.13) — a potential gain of +174% on today's $4.42. Buyers look set to stay in control over this stretch.
In 2034, LFCR is projected to trade between $10.66 and $22.77, averaging $14.97 — a potential gain of +239% from today's $4.42. That is up +24% on the projected 2033 average. Momentum favours further upside here.
Lifecore Biomedical, Inc.'s 2035 outlook centres on $15.99, within a $11.24 to $24.65 range. That is up +7% on the projected 2034 average. That marks a +262% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, LFCR could reach as high as $38.08, with a base case around $23.33 and support toward $15.48 — roughly +428% from $4.42. Momentum favours further upside here.
Expect LFCR to range from $29.15 to $86.02 through 2050. The $48.48 average target implies a +997% move from current prices. That is up +108% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in LFCR today (≈ 226.244344 LFCR) could be worth
$10,968.81
+$9,968.81 (+997%) by 2050 · US Dollar
Based on the average projected LFCR price of $48.48 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LFCRwould be worth at today's price.
$1,000 invested in LFCR on Jul 31, 2025 (≈ 142.857143 LFCR) would be worth
$631.43
-$368.57 (-36.9%) today · 0.63× · US Dollar
Based on a LFCR entry price of $7 vs. today's $4.42.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.33 | $1,020.79 | +2.1% |
| 1 month ago | $5.27 | $838.71 | -16.1% |
| 3 months ago | $5.26 | $840.3 | -16.0% |
| 6 months ago | $8.52 | $518.78 | -48.1% |
| 1 year ago | $7 | $631.43 | -36.9% |
| All time (5.0y) ago | $10.52 | $420.15 | -58.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LFCR forecast.
Our base-case forecast reaches $8.80 around 2030.
Implied market cap at $8.80: $330.08M
The long-term forecast envisions a gradual-to-strong upside from 2027 onward, with 2027 at an average price of $6.49 and 2028 at $7.30, rising through 2029 to $8.36 and into 2030 at $8.70. The 2030 forecast carries an average price of $8.70 with a 89.9 ROI and bullish sentiment. By 2031 the average is $9.14 and 2032 $9.72, both with bullish sentiment and rising ROI, culminating in 2033 at $11.27 (ROI 146) and 2034 at $14.14 (ROI 208.7), then 2035 at $15.16 (ROI 231.1).
The longer horizon shows substantial upside, with 2040 at $20.81 (ROI 354.3) and 2050 at $43.17 (ROI 842.7). These are estimates and not guarantees. Risks include market and macro conditions affecting execution of long-horizon targets.
Tap a question to reveal the answer.
2030 forecasted average price: $8.70; 2030 min: $6.41; 2030 max: $12.75; ROI: 89.9; sentiment: BULLISH.
Forecasts show a bullish trajectory from 2027 onward, with rising averages and increasing ROI through 2035 and beyond (e.g., 2027 avg $6.49, 2031 avg $9.14, 2035 avg $15.16; 2040 avg $20.81; 2050 avg $43.17). These figures are estimates and not guaranteed.
Yes. The 2030 max is $12.75, according to the forecast.
Current price: $4.58. Market cap: $171.79M.
RSI(14) is 40. SMA50 is $5.05, SMA200 is $6.32. Support is $4.57 and resistance is $5.80. The 30-day range is $3.80 to $5.52.
Lifecore Biomedical, Inc. Community Discussion
0Share your Lifecore Biomedical, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.